Home

Download

Statistics

Examples

Help

Contact

Editing gene: GALNT15 (CAeditome ID:117248)

Gene summary for GALNT15

Gene summary

Gene information	Gene symbol	GALNT15
	Gene ID	117248
	Gene name	polypeptide N-acetylgalactosaminyltransferase 15
	Synonyms	GALNACT15\|GALNT13\|GALNT7\|GALNTL2\|PIH5\|pp-GalNAc-T15
	Cytomap	3p25.1
	Type of gene	protein-coding
	Description	polypeptide N-acetylgalactosaminyltransferase 15UDP-GalNAc transferase T15UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15UDP-N-acetyl-alpha-D-ga
	Modification date	20210518
	UniProtAcc	Q8N3T1
	Context

Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Gene	GO ID	GO term	PubMed ID
GALNT15	GO:0030133	Polypeptide N-acetylgalactosaminyltransferase 15	0000054

Top

RNA A-to-I events for GALNT15

RNA A-to-I editing events across TCGA 33 cancers data sets based on Ensembl gene isoform structure.

RNA editing frequencies across 33 cancers of gene: ENSG00000131386.16

RNA A-to-I editing events in Cancer.

CAediting_261482(16202582, +), CAediting_261483(16202620, +), CAediting_261484(16206628, +), CAediting_261485(16209764, +), CAediting_261486(16213357, +), CAediting_261487(16215865, +), CAediting_261488(16215870, +), CAediting_261489(16225441, +), CAediting_261490(16225447, +), CAediting_261491(16225994, +), CAediting_261492(16228391, +), CAediting_261493(16228421, +), CAediting_261494(16228442, +), CAediting_261495(16228488, +), CAediting_261496(16228520, +), CAediting_261497(16228526, +), CAediting_261498(16228543, +), CAediting_261499(16228586, +), CAediting_261500(16228596, +), CAediting_261501(16228629, +), CAediting_261502(16230553, +), CAediting_261503(16230554, +), CAediting_261504(16230569, +), CAediting_261505(16230570, +), CAediting_261506(16230573, +), CAediting_261507(16230595, +), CAediting_261508(16230601, +), CAediting_261509(16230604, +), CAediting_261510(16230609, +), CAediting_261511(16230614, +), CAediting_261512(16230619, +), CAediting_261513(16230621, +), CAediting_261514(16230648, +), CAediting_261515(16230676, +), CAediting_261516(16230678, +), CAediting_261517(16230679, +), CAediting_261518(16230684, +), CAediting_261519(16230691, +), CAediting_261520(16230728, +), CAediting_261521(16230920, +), CAediting_261522(16230921, +), CAediting_261523(16230927, +), CAediting_261524(16230934, +),

Top

RNA editing positional annotations for GALNT15 using Annovar

Protein coding RNA editing(s).

CAeditome ID

Position

Variant type

ENST

NTchange

AAchange

SIFT_score

Polyphen2_HVAR_score

PROVEAN_pred

Gene structure information of RNA editing(s).

CAeditome ID	Position	Variant type
CAediting_261482	chr3_16202582_+	intronic
CAediting_261483	chr3_16202620_+	intronic
CAediting_261484	chr3_16206628_+	intronic
CAediting_261485	chr3_16209764_+	intronic
CAediting_261486	chr3_16213357_+	ncRNA_intronic
CAediting_261487	chr3_16215865_+	ncRNA_intronic
CAediting_261488	chr3_16215870_+	ncRNA_intronic
CAediting_261489	chr3_16225441_+	intronic
CAediting_261490	chr3_16225447_+	intronic
CAediting_261491	chr3_16225994_+	intronic
CAediting_261492	chr3_16228391_+	UTR3
CAediting_261493	chr3_16228421_+	UTR3
CAediting_261494	chr3_16228442_+	UTR3
CAediting_261495	chr3_16228488_+	UTR3
CAediting_261496	chr3_16228520_+	UTR3
CAediting_261497	chr3_16228526_+	UTR3
CAediting_261498	chr3_16228543_+	UTR3
CAediting_261499	chr3_16228586_+	UTR3
CAediting_261500	chr3_16228596_+	UTR3
CAediting_261501	chr3_16228629_+	UTR3
CAediting_261502	chr3_16230553_+	intronic
CAediting_261503	chr3_16230554_+	intronic
CAediting_261504	chr3_16230569_+	intronic
CAediting_261505	chr3_16230570_+	intronic
CAediting_261506	chr3_16230573_+	intronic
CAediting_261507	chr3_16230595_+	intronic
CAediting_261508	chr3_16230601_+	intronic
CAediting_261509	chr3_16230604_+	intronic
CAediting_261510	chr3_16230609_+	intronic
CAediting_261511	chr3_16230614_+	intronic
CAediting_261512	chr3_16230619_+	intronic
CAediting_261513	chr3_16230621_+	intronic
CAediting_261514	chr3_16230648_+	intronic
CAediting_261515	chr3_16230676_+	intronic
CAediting_261516	chr3_16230678_+	intronic
CAediting_261517	chr3_16230679_+	intronic
CAediting_261518	chr3_16230684_+	intronic
CAediting_261519	chr3_16230691_+	intronic
CAediting_261520	chr3_16230728_+	intronic
CAediting_261521	chr3_16230920_+	intronic
CAediting_261522	chr3_16230921_+	intronic
CAediting_261523	chr3_16230927_+	intronic
CAediting_261524	chr3_16230934_+	intronic

Repat-regional RNA editing(s).

CAeditome ID	Position	Repeat family	Repeat sub family	Repeat name
CAediting_261482	chr3_16202582_+	SINE	Alu	AluSx
CAediting_261483	chr3_16202620_+	SINE	Alu	AluSx
CAediting_261484	chr3_16206628_+	SINE	Alu	AluY
CAediting_261485	chr3_16209764_+	SINE	Alu	AluSz6
CAediting_261486	chr3_16213357_+	SINE	Alu	AluY
CAediting_261487	chr3_16215865_+	SINE	Alu	AluSc
CAediting_261488	chr3_16215870_+	SINE	Alu	AluSc
CAediting_261489	chr3_16225441_+	SINE	Alu	AluSx4
CAediting_261490	chr3_16225447_+	SINE	Alu	AluSx4
CAediting_261491	chr3_16225994_+	SINE	Alu	AluSz
CAediting_261492	chr3_16228391_+	SINE	Alu	AluSx
CAediting_261493	chr3_16228421_+	SINE	Alu	AluSx
CAediting_261494	chr3_16228442_+	SINE	Alu	AluSx
CAediting_261495	chr3_16228488_+	SINE	Alu	AluSx
CAediting_261496	chr3_16228520_+	SINE	Alu	AluSx
CAediting_261497	chr3_16228526_+	SINE	Alu	AluSx
CAediting_261498	chr3_16228543_+	SINE	Alu	AluSx
CAediting_261499	chr3_16228586_+	SINE	Alu	AluSx
CAediting_261500	chr3_16228596_+	SINE	Alu	AluSx
CAediting_261501	chr3_16228629_+	SINE	Alu	AluSx
CAediting_261507	chr3_16230595_+	Simple_repeat	Simple_repeat	(A)n
CAediting_261508	chr3_16230601_+	Simple_repeat	Simple_repeat	(A)n
CAediting_261509	chr3_16230604_+	Simple_repeat	Simple_repeat	(A)n
CAediting_261521	chr3_16230920_+	LINE	L1	L1PA8
CAediting_261522	chr3_16230921_+	LINE	L1	L1PA8
CAediting_261523	chr3_16230927_+	LINE	L1	L1PA8
CAediting_261524	chr3_16230934_+	LINE	L1	L1PA8

Top

RNA A-to-I editing events in the alternative splicing sites for GALNT15

RNA A-to-I editing(s) in the alternative splicing sites.

AStype

CAeditomID

Editing position

AS position

AS direction

Exonic location

Wildtype sequence

Wildtype splicing strength

RNA edited sequence

RNA edited splicing strength

Differential percent of spliced in (PSI) between RNA A-to-I edited and non-edited samples for ENSG00000131386.16.GALNT15.

Correlation between RNA A-to-I editing and PSI for ENSG00000131386.16.GALNT15.

Top

Differntial gene expression between RNA A-to-I edited versus non-edited samples for GALNT15

Differential gene expressions between RNA A-to-I edited and non-edited tumor samples.
* The grey color means N/A.

Correlation between RNA A-to-I editing and gene expression.

- Differentially expressed gene between RNA A-to-I edited samples versus non-edited samples.
* Click on the image to enlarge it in a new window.

LGG.CAediting_261509.ENSG00000131386.GALNT15.png
Soverview

LGG.CAediting_261511.ENSG00000131386.GALNT15.png
Soverview

LGG.CAediting_261517.ENSG00000131386.GALNT15.png
Soverview

LGG.CAediting_261518.ENSG00000131386.GALNT15.png
Soverview

Top

Protein coding region RNA A-to-I editings for GALNT15

- Lollipop plot for RNA A-to-I editings across protein structure.
* Click on the image to enlarge it in a new window.

Top

The effects of the RNA editing to the miRNA binding sites for GALNT15

**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page.

RNA A-to-I editing in the 3'-UTR regions of mRNA gained miRNA binding sites.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_261492	chr3_16228391_+	ENSG00000131386.16	ENST00000617544	hsa-miR-371a-3p	16228389	16228395	7mer-m8	16228374	16228396	144.00	-15.05
CAediting_261493	chr3_16228421_+	ENSG00000131386.16	ENST00000617544	hsa-miR-8053	16228417	16228422	6mer	16228399	16228423	140.00	-19.98
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-3176	16228439	16228445	7mer-m8	16228428	16228446	152.00	-22.34
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-3922-3p	16228439	16228445	7mer-m8	16228421	16228446	157.00	-22.43
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6878-3p	16228438	16228444	7mer-m8	16228425	16228445	144.00	-23.86
CAediting_261496	chr3_16228520_+	ENSG00000131386.16	ENST00000617544	hsa-miR-513a-5p	16228514	16228520	7mer-m8	16228504	16228521	156.00	-21.69
CAediting_261496	chr3_16228520_+	ENSG00000131386.16	ENST00000617544	hsa-miR-513a-5p	16228514	16228520	7mer-m8	16228504	16228521	156.00	-21.69
CAediting_261496	chr3_16228520_+	ENSG00000131386.16	ENST00000617544	hsa-miR-638	16228519	16228525	7mer-1a	16228501	16228525	151.00	-30.81
CAediting_261499	chr3_16228586_+	ENSG00000131386.16	ENST00000617544	hsa-miR-324-3p	16228579	16228585	7mer-m8	16228564	16228586	149.00	-24.91
CAediting_261499	chr3_16228586_+	ENSG00000131386.16	ENST00000617544	hsa-miR-4690-3p	16228583	16228590	8mer-1a	16228571	16228590	165.00	-31.39
CAediting_261499	chr3_16228586_+	ENSG00000131386.16	ENST00000617544	hsa-miR-5685	16228583	16228590	8mer-1a	16228570	16228590	149.00	-19.15
CAediting_261500	chr3_16228596_+	ENSG00000131386.16	ENST00000617544	hsa-miR-564	16228594	16228600	7mer-1a	16228582	16228600	151.00	-24.87
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-3156-3p	16228624	16228630	7mer-m8	16228611	16228631	141.00	-17.24
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-3156-3p	16228624	16228630	7mer-m8	16228611	16228631	141.00	-17.24
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-4433a-5p	16228625	16228631	7mer-m8	16228611	16228632	148.00	-20.47
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-5588-3p	16228626	16228632	7mer-m8	16228616	16228633	155.00	-18.42
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6777-3p	16228622	16228628	7mer-m8	16228611	16228629	146.00	-22.29
CAediting_261495	chr3_16228488_+	ENSG00000131386.16	ENST00000617544	hsa-miR-4742-3p	16228481	16228488	8mer-1a	16228466	16228488	142.00	-9.18
CAediting_261498	chr3_16228543_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6849-3p	16228536	16228542	7mer-m8	16228522	16228543	140.00	-18.03

RNA A-to-I editing in the 3'-UTR regions of mRNA lost miRNA binding sites.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_261496	chr3_16228520_+	ENSG00000131386.16	ENST00000617544	hsa-miR-10399-5p	16228515	16228521	7mer-m8	16228501	16228522	152	-11.23
CAediting_261493	chr3_16228421_+	ENSG00000131386.16	ENST00000617544	hsa-miR-125a-3p	16228418	16228425	8mer-1a	16228404	16228425	149	-18.88
CAediting_261498	chr3_16228543_+	ENSG00000131386.16	ENST00000617544	hsa-miR-3152-5p	16228541	16228547	7mer-m8	16228525	16228548	151	-19.12
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-3663-5p	16228439	16228445	7mer-m8	16228426	16228446	140	-19.33
CAediting_261497	chr3_16228526_+	ENSG00000131386.16	ENST00000617544	hsa-miR-5089-5p	16228519	16228525	7mer-m8	16228506	16228526	151	-15.19
CAediting_261492	chr3_16228391_+	ENSG00000131386.16	ENST00000617544	hsa-miR-512-3p	16228389	16228395	7mer-m8	16228375	16228396	149	-15
CAediting_261492	chr3_16228391_+	ENSG00000131386.16	ENST00000617544	hsa-miR-512-3p	16228389	16228395	7mer-m8	16228375	16228396	149	-15
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6131	16228440	16228446	7mer-m8	16228429	16228447	140	-16.72
CAediting_261496	chr3_16228520_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6504-3p	16228515	16228521	7mer-m8	16228503	16228522	140	-13.14
CAediting_261497	chr3_16228526_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6506-5p	16228520	16228526	7mer-m8	16228506	16228527	147	-15.75
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6794-3p	16228622	16228628	7mer-m8	16228612	16228629	150	-20.62
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6843-3p	16228438	16228444	7mer-m8	16228426	16228445	148	-20.39
CAediting_261494	chr3_16228442_+	ENSG00000131386.16	ENST00000617544	hsa-miR-6848-3p	16228438	16228444	7mer-m8	16228428	16228445	150	-22.55
CAediting_261501	chr3_16228629_+	ENSG00000131386.16	ENST00000617544	hsa-miR-924	16228628	16228633	6mer	16228615	16228634	140	-15.61

RNA A-to-I editing in lncRNA gained miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in lncRNA lost miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs lost binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to the 3'-UTR region of mRNA.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_688080	chr9_63819626_+	ENSG00000131386.16	ENST00000437509	hsa-miR-4477b	16231897	16231903	7mer-m8	16231885	16231904	157	-14.89
CAediting_980496	chr14_31014685_-	ENSG00000131386.16	ENST00000617544	hsa-miR-624-3p	16228674	16228679	6mer	16228660	16228680	143	-17.34
CAediting_393	chr1_1167164_+	ENSG00000131386.16	ENST00000617544	hsa-miR-200b-3p	16229022	16229028	7mer-m8	16229008	16229029	152	-9.1
CAediting_688080	chr9_63819626_+	ENSG00000131386.16	ENST00000617544	hsa-miR-4477b	16229353	16229359	7mer-m8	16229341	16229360	151	-12.73
CAediting_688081	chr9_63819627_+	ENSG00000131386.16	ENST00000617544	hsa-miR-4477b	16229555	16229562	8mer-1a	16229541	16229562	167	-15.68
CAediting_396018	chr5_1062918_-	ENSG00000131386.16	ENST00000437509	hsa-miR-4635	16231898	16231905	8mer-1a	16231882	16231905	145	-15.27
CAediting_1368054	chr19_46709310_-	ENSG00000131386.16	ENST00000617544	hsa-miR-320e	16228092	16228099	8mer-1a	16228082	16228099	141	-16.69
CAediting_1399425	chr20_1392958_-	ENSG00000131386.16	ENST00000617544	hsa-miR-6869-5p	16229387	16229393	7mer-m8	16229374	16229394	153	-24.47
CAediting_228905	chr2_188297554_+	ENSG00000131386.16	ENST00000617544	hsa-miR-561-3p	16228660	16228666	7mer-m8	16228646	16228667	140	-10.04
CAediting_228905	chr2_188297554_+	ENSG00000131386.16	ENST00000617544	hsa-miR-561-3p	16227959	16227965	7mer-m8	16227945	16227966	140	-11.29
CAediting_228905	chr2_188297554_+	ENSG00000131386.16	ENST00000617544	hsa-miR-561-3p	16228349	16228355	7mer-m8	16228335	16228356	152	-9.77
CAediting_468389	chr6_31355314_-	ENSG00000131386.16	ENST00000437509	hsa-miR-6891-5p	16231923	16231928	6mer	16231911	16231929	141	-20.15

RNA A-to-I editing in miRNAs lost binding to the 3'-UTR mRNA.

CAeditom_ID	Position	ENSG	ENST	miRNA	Targetscan start	Targetscan end	Targetscan score	Miranda start	Miranda end	Miranda score	Miranda energy
CAediting_442554	chr5_154685830_+	ENSG00000131386.16	ENST00000617544	hsa-miR-1303	16228225	16228231	7mer-m8	16228211	16228232	151	-11.85
CAediting_1351755	chr19_40282625_-	ENSG00000131386.16	ENST00000617544	hsa-miR-641	16229515	16229520	6mer	16229498	16229521	141	-15.9

Differentially expressed gene-miRNA network

Top

The effects of the RNA editing to the stability of the RNA structures for GALNT15

- RNA A-to-I editing in mRNA.
* Click on the image to enlarge it in a new window.

ENST	ENST type	RNA structure without RNA A-to-I editing.	RNA structure with RNA A-to-I editing.
ENST00000339732.8	protein_coding
ENST00000617544.3	protein_coding

RNA A-to-I editing in RNA structures for Minimum free energy (MFE).

CAeditom_ID	ENST	Editing_Position	MFE_withoneAI	MFE_withoutAI	MFE_withmultipleAI
CAediting_261492	ENST00000339732.8	chr3_16228391_+	-1591.90	-1589.00	-1595.80
CAediting_261493	ENST00000339732.8	chr3_16228421_+	-1588.80	-1589.00	-1595.80
CAediting_261494	ENST00000339732.8	chr3_16228442_+	-1589.30	-1589.00	-1595.80
CAediting_261495	ENST00000339732.8	chr3_16228488_+	-1589.00	-1589.00	-1595.80
CAediting_261496	ENST00000339732.8	chr3_16228520_+	-1590.50	-1589.00	-1595.80
CAediting_261497	ENST00000339732.8	chr3_16228526_+	-1588.30	-1589.00	-1595.80
CAediting_261498	ENST00000339732.8	chr3_16228543_+	-1590.90	-1589.00	-1595.80
CAediting_261499	ENST00000339732.8	chr3_16228586_+	-1590.80	-1589.00	-1595.80
CAediting_261500	ENST00000339732.8	chr3_16228596_+	-1588.40	-1589.00	-1595.80
CAediting_261501	ENST00000339732.8	chr3_16228629_+	-1587.40	-1589.00	-1595.80
CAediting_261492	ENST00000617544.3	chr3_16228391_+	-835.87	-832.97	-843.40
CAediting_261493	ENST00000617544.3	chr3_16228421_+	-832.77	-832.97	-843.40
CAediting_261494	ENST00000617544.3	chr3_16228442_+	-833.27	-832.97	-843.40
CAediting_261495	ENST00000617544.3	chr3_16228488_+	-832.97	-832.97	-843.40
CAediting_261496	ENST00000617544.3	chr3_16228520_+	-834.47	-832.97	-843.40
CAediting_261497	ENST00000617544.3	chr3_16228526_+	-832.27	-832.97	-843.40
CAediting_261498	ENST00000617544.3	chr3_16228543_+	-834.87	-832.97	-843.40
CAediting_261499	ENST00000617544.3	chr3_16228586_+	-834.77	-832.97	-843.40
CAediting_261500	ENST00000617544.3	chr3_16228596_+	-834.10	-832.97	-843.40
CAediting_261501	ENST00000617544.3	chr3_16228629_+	-831.37	-832.97	-843.40

Top

Relation with ADAR for GALNT15

Correlation between ADAR gene expression and RNA editing frequency

Cancer	CAeditomID	position	ADAR1 (p-val)	ADAR1 (coeff.)	ADAR2 (p-val)	ADAR2 (coeff.)	ADAR3 (p-val)	ADAR3 (coeff.)
LGG	CAediting_261502	chr3_16230553_+	1.85579373044865e-14	0.49020215617396	.	.	.	.
LGG	CAediting_261509	chr3_16230604_+	1.21114544095637e-11	0.300514685618185	.	.	.	.
GBM	CAediting_261509	chr3_16230604_+	8.62799656660171e-07	0.390293678089132	.	.	.	.
SARC	CAediting_261509	chr3_16230604_+	7.74699679083408e-06	0.422877262009553	.	.	.	.
LGG	CAediting_261510	chr3_16230609_+	1.85363795119699e-13	0.45934618018465	.	.	.	.
GBM	CAediting_261510	chr3_16230609_+	1.16584776280253e-06	0.509825915767061	.	.	.	.
LGG	CAediting_261511	chr3_16230614_+	2.12202917117028e-19	0.401888482203679	.	.	.	.
BRCA	CAediting_261511	chr3_16230614_+	0.016240704230003	0.20808411386144	.	.	.	.
GBM	CAediting_261511	chr3_16230614_+	9.26390680093406e-11	0.503557736200652	.	.	.	.
KIRC	CAediting_261511	chr3_16230614_+	0.00345300625598517	0.182835692562682	.	.	.	.
SARC	CAediting_261511	chr3_16230614_+	0.000102443589483802	0.411117055723769	.	.	.	.
LGG	CAediting_261516	chr3_16230678_+	2.98203286744238e-07	0.461756093580888	.	.	.	.
LGG	CAediting_261517	chr3_16230679_+	1.04967491297135e-26	0.468611151562823	.	.	.	.
GBM	CAediting_261517	chr3_16230679_+	2.07266690601963e-08	0.467365239443762	.	.	.	.
SARC	CAediting_261517	chr3_16230679_+	0.000399435403916719	0.361495325154497	.	.	.	.
LGG	CAediting_261518	chr3_16230684_+	3.85420942007507e-25	0.499664137405435	.	.	.	.
GBM	CAediting_261518	chr3_16230684_+	2.58095722001215e-05	0.375464056733531	.	.	.	.
SARC	CAediting_261518	chr3_16230684_+	9.00647073392835e-05	0.469728495227677	.	.	.	.

Top

Relation with cancer stages for GALNT15

Correlation between Cancer stages and RNA editing frequency

Cancer	Stage_type	CAeditomID	position	P-val	Coeff.
BRCA	pathologic_stage	CAediting_261509	chr3_16230604_+	0.0156833196314943	0.223907539115188
BRCA	pathologic_stage	CAediting_261517	chr3_16230679_+	0.0102444047267085	0.236524024116673
BRCA	pathologic_stage	CAediting_261518	chr3_16230684_+	0.0039028679678709	0.331578505698489
KIRC	pathologic_stage	CAediting_261510	chr3_16230609_+	0.0351832023792848	0.235863923492914
KIRC	pathologic_stage	CAediting_261518	chr3_16230684_+	0.0482639736353792	0.158915533806992

Top

Relation with survival for GALNT15

Correlation between RNA editing and survival

Cancer

CAeditomID

position

KMpvalue

Coxpvalue

CoxHR

Top

RelatedDrugs for GALNT15

Approved drugs targeting this gene.
(DrugBank Version 5.1.8 2021-01-03)

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

RelatedDiseases for GALNT15

Diseases associated with this gene.
(DisGeNet 7.0)

Gene

Disease ID

Disease name

# pubmeds

Source

	Gene summary
	RNA A-to-I events
	Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples
	Protein coding region RNA A-to-I editings
	The effects of the RNA editing to the miRNA binding sites
	The effects of the RNA editing to the stability of the RNA structures
	Relation with ADAR
	Relation with cancer stages
	Relation with survival state
	Related drugs with this gene
	Related diseases with this gene